Skip to main content

Grafa News and Videos — Page 1050

Grafa Headlines

Latest

Grafa

LIXTE announces strategic transformation and pivot into AI energy infrastructure via acquisition of NOMAD

LIXTE Biotechnology (NASDAQ:LIXT) entered into a definitive agreement to acquire 100% of NOMAD Transportable Power Systems, executing a complete structural transformation away from its legacy clinical-stage oncology pipeline into a dedicated public-market platform for AI and utility energy infrastructure.

Read more: LIXTE announces strategic transformation and pivot into AI energy infrastructure via acquisition of NOMAD
Grafa

GSK gains transatlantic orphan drug designations for myelofibrosis asset in rare disease pivot

GSK (NYSE:GSK) announced that momelotinib, its approved Janus kinase (JAK) inhibitor, has received Orphan Drug Designation from both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of VEXAS syndrome.

Read more: GSK gains transatlantic orphan drug designations for myelofibrosis asset in rare disease pivot

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift